Viewing Study NCT07405151


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 2:28 AM
Study NCT ID: NCT07405151
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-12
First Post: 2026-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module